(Q42502183)

1 November 2017

title

Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease (English)

1 reference

1 November 2017

0 references

1 reference

Nicolas Arlicot

2

0 references

Denis Guilloteau

object named as

Denis Guilloteau

6

0 references

Sylvie Chalon

object named as

Sylvie Chalon

7

0 references

author name string

Serge Maia

1

1 reference

1 November 2017

Emilie Vierron

3

1 reference

1 November 2017

Sylvie Bodard

4

1 reference

1 November 2017

Jackie Vergote

5

1 reference

1 November 2017

publication date

15 February 2012

1 reference

1 November 2017

1 reference

1 November 2017

volume

66

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

573-583

1 reference

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation

1 November 2017

cites work

1 reference

[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

21 January 2018

1 reference

Labelling of "Peripheral-Type" Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

21 January 2018

1 reference

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

21 January 2018

1 reference

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.

21 January 2018

1 reference

Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair

21 January 2018

1 reference

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

21 January 2018

1 reference

Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra

21 January 2018

1 reference

PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter

21 January 2018

1 reference

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

Neuroglia in neurodegeneration

21 January 2018

1 reference

Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamine

21 January 2018

1 reference

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization

21 January 2018

1 reference

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

21 January 2018

1 reference

Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS).

21 January 2018

1 reference

Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation.

21 January 2018

1 reference

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

Neuroinflammation in the living brain of Parkinson's disease

21 January 2018

1 reference

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.

21 January 2018

1 reference

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

21 January 2018

1 reference

Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.

21 January 2018

1 reference

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

Life and death of microglia

21 January 2018

1 reference

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

21 January 2018

1 reference

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

21 January 2018

1 reference

Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and functional significance.

21 January 2018

1 reference

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging

21 January 2018

1 reference

A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation

21 January 2018

1 reference

Inflammation as a causative factor in the aetiology of Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.21543

1 reference

1 November 2017

1 reference